Radioimmunoassays for these fragments were the first tests available for diagnosing primary hyperparathyroidism and monitoring hyperparathyroidism secondary to renal disease, but because the PTH breakdown rate varies with calcium level and renal excretion can be decreased when advanced chronic kidney disease is present, second-generation assays that measure the intact PTH molecule are used.